• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, August 31, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

AGA releases official guidance for patients with IBD during the COVID-19 pandemic

Bioengineer by Bioengineer
April 10, 2020
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Many patients with IBD who develop COVID-19 should stop their medication

IMAGE

Credit: American Gastroenterology Association

Bethesda, Maryland (April 10, 2020) — Today, the American Gastroenterological Association (AGA) published new COVID-19 guidance for gastroenterologists treating patients with inflammatory bowel disease (IBD): AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary.

While the COVID-19 pandemic is a global health emergency, patients with IBD have particular concerns for their risk for infection and management of their medical therapies. This clinical practice update incorporates the emerging understanding of COVID-19 and summarizes available guidance for patients with IBD and the providers who take care of them.

Recommendations for gastroenterologists & their patients who have IBD:

    1. During this pandemic, patients with IBD should continue IBD therapies including scheduled infusions.

    2. Having IBD does not appear to increase the risk of SARS-CoV-2 infection or the development of COVID-19.

    3. Instructions for patients with IBD who develop COVID-19 (fever, respiratory symptoms, digestive symptoms, etc.):

      a. Stop thiopurines, methotrexate, tofacitinib.

      b. Stop biological therapies (including anti-TNF, ustekinumab, vedolizumab).

      c. Can restart therapies after complete resolution of COVID-19 symptoms. Patients should

      always speak with their health care team before stopping any medication.

    4. Doctors should submit cases of IBD and confirmed COVID-19 to the SECURE-IBD registry at
    COVIDIBD.org.

###

This paper, authored by leading IBD experts David T. Rubin, Joseph D. Feuerstein, Andrew Y. Wang, and Russell D. Cohen, is published in Gastroenterology, the official journal of the AGA. This expert commentary was commissioned and approved by the AGA Institute Clinical Practice Updates Committee and the AGA Governing Board to provide timely perspective on a topic of high clinical importance to AGA membership.

RESOURCES

Download decision support tool & quick reference chart for social sharing.

ABOUT IBD

Inflammatory bowel disease (IBD) is a group of chronic immune disorders, including Crohn’s disease and ulcerative colitis. These conditions can cause abdominal pain, diarrhea and weight loss. Symptoms and progression of the disease can often be controlled by medication, but sometimes surgery is needed, as well. In the U.S., 3.1 million people have IBD. Learn more about IBD in the AGA GI Patient Center.

REFERENCE

Rubin DT, Feuerstein JD, Wang AY, Cohen RD, AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary, Gastroenterology (2020), https://doi.org/10.1053/j.gastro.2020.04.012

Media Contact
Courtney Reed
[email protected]

Related Journal Article

http://dx.doi.org/10.1053/j.gastro.2020.04.012

Tags: GastroenterologyHealth ProfessionalsInternal MedicineLiverMedicine/HealthUrogenital System
Share12Tweet8Share2ShareShareShare2

Related Posts

Endoplasmic Reticulum Stress in PCOS: Therapeutic Insights

August 31, 2025

Pediatric Obesity Linked to Foot Shape Changes

August 31, 2025

Modeling Musculoskeletal Forces: Experimental Validation Insights

August 31, 2025

Enhancing Perioperative Oncology: Insights from NSCLC

August 31, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    152 shares
    Share 61 Tweet 38
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Do people and monkeys see colors the same way?

    112 shares
    Share 45 Tweet 28

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Bioinformatics Unveils Biomarkers for Liver Cancer Recurrence

Endoplasmic Reticulum Stress in PCOS: Therapeutic Insights

Pediatric Obesity Linked to Foot Shape Changes

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.